Jazz Pharmaceuticals plc — Director's Dealing 2010

Aug 27, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: JAZZ PHARMACEUTICALS INC (JAZZ)
CIK: 0001232524
Period of Report: 2010-08-25

Reporting Person: CRESSEY BRYAN C (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-08-25	Option (right to buy)	$8.23	A	12500	Acquired	2020-08-25	Comm Stock (12500)	Direct

Footnotes

F1: The option shares shall vest in a series of twelve (12) successive equal installments upon completion of each month of Continuous Service (as defined under the Issuer's 2007 Non-Employee Directors Stock Option Plan, as amended) over the one (1)-year period measured from August 15, 2010.